FDA Approves Asthma Indication for Dupixent® (dupilumab)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/28/2026

1. SPCX
2. NVDA
3. KOD
4. MIRM
5. USO
6. META
7. LLY
8. SPY
9. MDB
10. MU

Go back to FDA Approves Asthma Indication for Dupixent® (dupilumab)
Regeneron (NASDAQ: REGN) Delayed: 761.40 -26.64 (3.38%)
Previous Close $788.04    52 Week High $592.36 
Open $778.09    52 Week Low $325.35 
Day High $780.95    P/E 199.84 
Day Low $752.71    EPS $3.81 
Volume 172,610